Esperion

Facts.

ESPR has to roll the dice to try to get additional funding.

Not encouraging.
ROTD_200.jpg
 




KOLs are getting on board following the release of the parsed primary prevention data from CLEAR, which is definitely helping those in the field who promote the product. The end game is reducing events and the data don’t lie.
 




KOLs are getting on board following the release of the parsed primary prevention data from CLEAR, which is definitely helping those in the field who promote the product. The end game is reducing events and the data don’t lie.

More gibberish from the Scientific Hires. KOL's are a worthless role and offer no help to field sales. This drug is toast ans has been for sometime
 
































Stock price is firming up, and it’s becoming more apparent that the 300 million from DS will be in our coffers in the near future. This helps extend the runway significantly, and provides us with the financial flexibility and stability to help ensure we reach our ultimate goals. Great bright future ahead!
 








Firming the stock price up!! Thats great ! So excited !! My stock was once worth $78.00 a share in 2020 and now it's $1.40 range. This sounds like an awesome runway. We're just waiting with cup in hand for the DS payout. Life is great!!
 




Later stage investors are typically the ones that are most richly rewarded, clearly you don’t know anything about finance. I’m not sure you know anything about anything long ESPR and look for a 10 bagger.